Australia offers financial aid to early phase clinical trials in APAC

Leading Australian CRO Avance Clinical on 3 April 2020 detailed the top reasons it's APAC biotechs selected Australia fo...

April 10, 2020 | Friday | News
Asia-Pacific accounts for 40% of global clinical trials initiated in 2019

The Asia-Pacific (APAC) has emerged as the most prominent region for conducting clinical trials, accounting for over 40%...

March 30, 2020 | Monday | Analysis
Agilex Biolabs appoints Dr Caroline Popper for Board Chair

Award-winning Australian bioanalytical laboratory Agilex Biolabs announced on 2 April 2020 that it has appointed US-base...

April 2, 2020 | Thursday | News
WHO enrolls Spain and Norway for COVID-19 initial Clinical trial

"Spain and Norway are ready to enrol their patients for COVID-19 clinical trial", announces Dr Tedros Adhanom Ghebreyesu...

March 28, 2020 | Saturday | News
Novotech nominated for Citeline Award for being excellent APAC CRO

Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist in two categories for the Citelin...

March 23, 2020 | Monday | News
Avance Clinical to deliver rapid results for urgent COVID-19 trials

Australian CRO Avance Clinical has said that Australia’s fast regulatory approval environment, key opinion leader ...

March 20, 2020 | Friday | News
Molecular docking show SARS-CoV-2 inhibition by Linebacker & Equivir

SGX-listed Singapore eDevelopment Ltd has announced that its wholly-owned U.S. biomedical subsidiary Impact BioMedical, ...

March 18, 2020 | Wednesday | News
New GeoMap Tools Gets Patient Recruitment Back on Track

Award-winning global leader in digital patient recruitment GeoMap Clinical by TrialWire announced on 11 March 2020 that ...

March 11, 2020 | Wednesday | News
Novotech Wins CRO Contract for Covid-19 Clinical Trial in South Korea

Asia-Pacific’s largest specialist biotech CRO Novotech has been selected for the Komipharm International clin...

March 9, 2020 | Monday | News
WuXi Biologics congratulates Immutep on positive interim data for IMP-321

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...

February 24, 2020 | Monday | News
AVROBIO announces clinical and regulatory progress for Gaucher Disease Program

US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic...

January 17, 2020 | Friday | News
PPD expands clinical capabilities in China

PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chin...

January 15, 2020 | Wednesday | News
Genome & Company inks clinical trial collaboration

Genome & Company, a clinical-stage biotechnology company based in Seongnam, Republic of Korea, has announced th...

January 15, 2020 | Wednesday | News
Hummingbird Publishes Preclinical efficacy of HMBD-001 in HER3 driven Cancers

Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrou...

January 8, 2020 | Wednesday | News
CStone initiates CS1001 trial to treat ESCC in China

CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Co...

January 8, 2020 | Wednesday | News
Transgene, NEC initiate trials with AI-Powered Cancer Vaccine

French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...

January 7, 2020 | Tuesday | News
Eisai presented research data on Eribulin (Halaven) at 42nd Annual SABCS2019

Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...

December 16, 2019 | Monday | News
Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference

Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading...

December 31, 2019 | Tuesday | News